Govt reviewing move to withdraw customs duty exemption for

Image
Press Trust of India New Delhi
Last Updated : Feb 09 2016 | 11:07 PM IST
Fearing a rise in prices of life- saving medicines, the government is reviewing its decision to withdraw customs duty exemption for the import of 74 drugs, including those for treating cancer, AIDS and haemophilia.
A notification issued last week by Central Board of Excise and Customs had announced that customs duty exemption on the import of 74 drugs was withdrawn.
"The matter (of withdrawal of exemption) is being reviewed," sources in the Health Ministry said.
The move is expected to make the treatment of a multitude of diseases costlier, including kidney stones, heart rhythm disorders, diabetes, Parkinson's disease, bone diseases, bacterial infections, anaesthetic medication, allergies, arthritis, lupus, menopause, glaucoma, poisoning by a chemical or pesticide, growth failure in children and ulcerative colitis.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 09 2016 | 11:07 PM IST

Next Story